Liberato Di Lullo

Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial

Sabino De Placido, Ciro Gallo, Michelino De Laurentiis et al. · The Lancet Oncology · 2018 · 88 citations · Full text

Medicine, Endocrinology, Oncology +11

Randomized, multicenter, phase II study of gemcitabine plus cisplatin versus gemcitabine plus carboplatin in patients with advanced non-small cell lung cancer

Paola Mazzanti, Cristian Massacesi, Marco Rocchi et al. · Lung Cancer · 2003 · 75 citations

Medicine, Oncology, Pharmacology +14

Phase I–II studies on accelerated IMRT in breast carcinoma: Technical comparison and acute toxicity in 332 patients

A.G. Morganti, Savino Cilla, Vincenzo Valentini et al. · Radiotherapy and Oncology · 2008 · 71 citations

Medicine, Oncology, Radiation Oncology +12

Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: Results of a phase II study

L. Caravatta, Gilbert D. A. Padula, V. Picardi et al. · Acta Oncologica · 2011 · 30 citations · Full text

Medicine, Oncology, Surgery +17

Immunotherapy Bridge 2017 and Melanoma Bridge 2017: meeting abstracts

David Carbone, Michael F. Sharpnack, Kai He et al. · Journal of Translational Medicine · 2018 · 28 citations · Full text

Life Sciences, Immunology, Oncology +17